Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins.
AML
HDACs
chromosomal translocation
epigenetic modification
leukemogenesis
oncogenic fusion protein
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
07
2021
accepted:
11
08
2021
entrez:
20
9
2021
pubmed:
21
9
2021
medline:
21
9
2021
Statut:
epublish
Résumé
Accurate orchestration of gene expression is critical for the process of normal hematopoiesis, and dysregulation is closely associated with leukemogenesis. Epigenetic aberration is one of the major causes contributing to acute myeloid leukemia (AML), where chromosomal rearrangements are frequently found. Increasing evidences have shown the pivotal roles of histone deacetylases (HDACs) in chromatin remodeling, which are involved in stemness maintenance, cell fate determination, proliferation and differentiation,
Identifiants
pubmed: 34540702
doi: 10.3389/fonc.2021.741746
pmc: PMC8440836
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
741746Informations de copyright
Copyright © 2021 Zhang, Gao and Yu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancers (Basel). 2019 Dec 07;11(12):
pubmed: 31817911
Ann Lab Med. 2019 May;39(3):311-316
pubmed: 30623623
Haematologica. 2019 Nov;104(11):2225-2240
pubmed: 30819918
Int J Mol Sci. 2019 Jan 16;20(2):
pubmed: 30654457
Exp Hematol. 2015 Aug;43(8):609-24
pubmed: 26118500
J Biomed Biotechnol. 2011;2011:928326
pubmed: 21151616
Blood. 2017 Aug 10;130(6):699-712
pubmed: 28607134
Clin Epigenetics. 2019 Oct 7;11(1):137
pubmed: 31590682
Cell Biosci. 2015 Nov 04;5:60
pubmed: 26539288
Nat Rev Clin Oncol. 2020 Apr;17(4):204-232
pubmed: 31792354
Cold Spring Harb Perspect Med. 2016 Oct 3;6(10):
pubmed: 27599530
Sci Rep. 2018 Aug 30;8(1):13072
pubmed: 30166563
Trends Pharmacol Sci. 2017 Apr;38(4):363-377
pubmed: 28139258
Oncogene. 2004 May 24;23(24):4255-62
pubmed: 15156181
Mol Cancer Res. 2019 Jun;17(6):1241-1252
pubmed: 30814129
Adv Exp Med Biol. 2017;962:65-81
pubmed: 28299651
Oncol Rep. 2019 Jul;42(1):3-19
pubmed: 31059069
Oncogene. 2014 Jan 23;33(4):403-10
pubmed: 23435431
Elife. 2020 Jun 05;9:
pubmed: 32501215
Genome Biol. 2019 Nov 20;20(1):245
pubmed: 31747960
Phys Biol. 2013 Apr;10(2):026006
pubmed: 23481318
Mol Biol Cell. 2014 Dec 15;25(25):4187-94
pubmed: 25298398
Cell Stem Cell. 2015 Nov 5;17(5):597-610
pubmed: 26387755
Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a018713
pubmed: 24691964
Cancer Med. 2020 Nov;9(22):8457-8467
pubmed: 32970934
Leukemia. 2017 Nov;31(11):2491-2502
pubmed: 28360416
Blood. 2016 Jan 7;127(1):42-52
pubmed: 26660432
Blood. 2013 May 2;121(18):3714-7
pubmed: 23426948
Genes Dev. 2013 Apr 15;27(8):819-35
pubmed: 23630073
Trends Pharmacol Sci. 2015 Jul;36(7):481-92
pubmed: 26013035
J Pak Med Assoc. 1993 Oct;43(10):200-3
pubmed: 8114248
Mol Cell. 2005 May 27;18(5):601-7
pubmed: 15916966
Exp Hematol. 2020 May;85:57-69
pubmed: 32437908
Cancer Lett. 2007 Jun 28;251(2):179-86
pubmed: 17125917
Nat Genet. 2020 Dec;52(12):1271-1281
pubmed: 33257899
Blood. 2009 Mar 26;113(13):3070-9
pubmed: 19179469
Methods Mol Biol. 2016;1436:129-45
pubmed: 27246213
Blood Cancer J. 2016 Jul 01;6(7):e441
pubmed: 27367478
Curr Opin Genet Dev. 2016 Feb;36:100-6
pubmed: 27162099
Curr Drug Targets. 2020;21(3):302-317
pubmed: 31465284
Chin Med J (Engl). 2020 Mar 20;(6):699-715
pubmed: 32044818
J Cell Mol Med. 2011 Sep;15(9):1833-46
pubmed: 21435179
Blood. 2020 Jan 16;135(3):191-207
pubmed: 31750881
Expert Opin Ther Targets. 2021 Jan;25(1):75-85
pubmed: 33275850
Leukemia. 2017 Apr;31(4):995-997
pubmed: 28074065
EMBO J. 2004 Mar 10;23(5):1144-54
pubmed: 14976551
J Pharmacol Exp Ther. 2007 Jun;321(3):953-60
pubmed: 17389244
Biochem Cell Biol. 2001;79(3):243-52
pubmed: 11467738
Cancer Manag Res. 2020 Mar 25;12:2231-2253
pubmed: 32273762
Stem Cells. 2020 Nov;38(11):1366-1374
pubmed: 32745287
Oncogene. 2019 Jan;38(2):261-272
pubmed: 30093631
J Immunol. 2008 Apr 1;180(7):4402-8
pubmed: 18354160
Mol Oncol. 2007 Jun;1(1):19-25
pubmed: 19383284
Oncogenesis. 2014 Nov 17;3:e127
pubmed: 25402609
J Biol Chem. 2020 Mar 27;295(13):4212-4223
pubmed: 32071087
Ann Lab Med. 2016 Mar;36(2):85-100
pubmed: 26709255
Leukemia. 2019 Jul;33(7):1620-1634
pubmed: 30737482
PLoS One. 2019 Dec 23;14(12):e0226435
pubmed: 31869378
Cell Mol Life Sci. 2019 Sep;76(17):3263-3282
pubmed: 30982077
J Proteome Res. 2018 Aug 3;17(8):2657-2667
pubmed: 29972300
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15751-6
pubmed: 21896721
J Biomed Biotechnol. 2011;2011:104631
pubmed: 21629739
Mol Cell. 2021 Feb 4;81(3):418-420
pubmed: 33545056
Int J Oral Sci. 2019 Jun 10;11(2):20
pubmed: 31201303
Blood. 2011 Nov 17;118(20):5366-7
pubmed: 22096254
Leukemia. 2019 Apr;33(4):945-956
pubmed: 30470836
J Clin Med. 2020 Mar 16;9(3):
pubmed: 32188030
Oncogenesis. 2014 Jun 16;3:e106
pubmed: 24932908
Cell Rep. 2020 Jan 14;30(2):299-307.e3
pubmed: 31940477
Mol Ther Oncolytics. 2020 Aug 08;18:623-630
pubmed: 33005729
Ann Hematol. 2017 Apr;96(4):559-565
pubmed: 28058491
Neuroscience. 2020 Apr 15;432:247-259
pubmed: 32112918
Blood. 2009 Jan 22;113(4):883-6
pubmed: 19036704
Oncotarget. 2018 May 22;9(39):25647-25660
pubmed: 29876014
Cell Death Dis. 2014 Oct 23;5:e1491
pubmed: 25341045
Br J Cancer. 2011 Feb 15;104(4):554-8
pubmed: 21245861
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):348-355
pubmed: 27913501
Exp Mol Med. 2020 Feb;52(2):204-212
pubmed: 32071378
Front Oncol. 2020 Apr 21;10:485
pubmed: 32373519
Nucleic Acids Res. 2020 Apr 6;48(6):2912-2923
pubmed: 31970414
Blood. 2018 Sep 20;132(12):1241-1247
pubmed: 30049809
Front Oncol. 2019 Sep 06;9:850
pubmed: 31552175
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8342-7
pubmed: 12829790
Exp Hematol. 2020 Dec;92:19-31
pubmed: 32950598
Am J Hematol. 2020 Nov;95(11):1368-1398
pubmed: 32833263
Front Oncol. 2021 Feb 08;10:610820
pubmed: 33628731
PLoS Genet. 2018 Jun 7;14(6):e1007362
pubmed: 29879107
Epigenetics. 2014 Nov;9(11):1511-20
pubmed: 25482492
Cancers (Basel). 2020 Apr 14;12(4):
pubmed: 32295268
Mol Cell. 2013 Jul 11;51(1):57-67
pubmed: 23791785
Nat Rev Cancer. 2019 May;19(5):255-269
pubmed: 30962549
Oncogene. 2004 May 24;23(24):4270-4
pubmed: 15156183
Blood Adv. 2020 Jan 14;4(1):229-238
pubmed: 31935293
Cancers (Basel). 2020 Mar 08;12(3):
pubmed: 32182684
Biochemistry (Mosc). 2010 Dec;75(13):1650-66
pubmed: 21417999
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Front Oncol. 2019 May 22;9:432
pubmed: 31192132
Oncogene. 2001 Sep 10;20(40):5660-79
pubmed: 11607817
Front Oncol. 2018 Mar 29;8:92
pubmed: 29651407
FEBS Lett. 2010 Jun 18;584(12):2662-9
pubmed: 20388510
Chembiochem. 2021 Feb 15;22(4):595-612
pubmed: 32864867
Cell. 2001 Mar 9;104(5):755-67
pubmed: 11257229
Cancer Genet. 2015 Apr;208(4):143-7
pubmed: 25843568
Nat Immunol. 2009 Jan;10(1):92-100
pubmed: 19011628
ACS Omega. 2020 May 11;5(20):11473-11480
pubmed: 32478236
Leukemia. 2012 Jul;26(7):1630-7
pubmed: 22333881
Nat Rev Genet. 2009 Jan;10(1):32-42
pubmed: 19065135
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067680
Cancer Chemother Pharmacol. 2019 Feb;83(2):255-264
pubmed: 30430228
Nat Rev Cancer. 2015 Feb;15(2):81-95
pubmed: 25592647
Br J Cancer. 2015 Feb 3;112(3):413-8
pubmed: 25247321
Front Immunol. 2021 Apr 02;12:640369
pubmed: 33868269
Genes (Basel). 2020 May 15;11(5):
pubmed: 32429325
Semin Hematol. 2019 Apr;56(2):90-95
pubmed: 30926096
Mol Med Rep. 2019 May;19(5):4147-4158
pubmed: 30942411
Nat Rev Immunol. 2018 Oct;18(10):617-634
pubmed: 30022149
J Transl Int Med. 2017 Jun 30;5(2):69-71
pubmed: 28721337
Sci Rep. 2020 Jul 29;10(1):12761
pubmed: 32728112
J Cell Physiol. 2006 Sep;208(3):594-601
pubmed: 16741927
Blood. 2008 Aug 15;112(4):1392-401
pubmed: 18511808
Handb Exp Pharmacol. 2011;206:39-56
pubmed: 21879445
Cells. 2020 Dec 13;9(12):
pubmed: 33322186
Cell Res. 2007 Mar;17(3):195-211
pubmed: 17325692
BMC Genomics. 2019 Jul 27;20(1):613
pubmed: 31351464
Cancer Cell. 2010 Feb 17;17(2):173-85
pubmed: 20159609
Biomed Pharmacother. 2020 Nov;131:110607
pubmed: 32841898
Nucleic Acids Res. 2020 Jan 24;48(2):646-664
pubmed: 31754707
Curr Top Med Chem. 2016;16(7):714-31
pubmed: 26303421
Haematologica. 2003 Mar;88(3):351-2
pubmed: 12651278
Cancer Genet Cytogenet. 2004 Nov;155(1):47-56
pubmed: 15527902
Blood Cancer J. 2021 Feb 22;11(2):41
pubmed: 33619261
Expert Rev Proteomics. 2020 Jan;17(1):1-10
pubmed: 31945303
Blood. 2013 Mar 28;121(13):2424-31
pubmed: 23325837
Clin Epigenetics. 2012 Mar 12;4(1):5
pubmed: 22414492
Mol Cancer. 2020 Jan 7;19(1):5
pubmed: 31910827
Front Cell Dev Biol. 2020 Sep 04;8:844
pubmed: 33015043
J Mol Biol. 2021 Mar 19;433(6):166678
pubmed: 33065110
Adv Biomed Res. 2019 Oct 31;8:63
pubmed: 31737580
Nat Rev Mol Cell Biol. 2014 Nov;15(11):703-8
pubmed: 25315270
FASEB J. 2020 Oct;34(10):13140-13155
pubmed: 32862458
Mol Cell Biol. 2001 Sep;21(18):6091-101
pubmed: 11509652
Exp Ther Med. 2020 Oct;20(4):2923-2940
pubmed: 32855658
Int J Hematol. 2001 Oct;74(3):252-7
pubmed: 11721959
Biochim Biophys Acta Gene Regul Mech. 2020 Mar;1863(3):194503
pubmed: 32061883
Clin Transl Med. 2020 Aug;10(4):e154
pubmed: 32898337
Mol Cells. 2020 Feb 29;43(2):99-106
pubmed: 32024352
Zhonghua Er Ke Za Zhi. 2017 Jan 2;55(1):15-18
pubmed: 28072953
Trends Biochem Sci. 2021 Apr;46(4):258-269
pubmed: 33308996
Leukemia. 2003 Apr;17(4):731-7
pubmed: 12682630
Genes Dev. 2016 Sep 15;30(18):2021-2041
pubmed: 27798847
Oncogene. 2004 Nov 18;23(54):8777-84
pubmed: 15467736
Cell Stress Chaperones. 2020 Jan;25(1):173-191
pubmed: 31900865
Cancers (Basel). 2019 Nov 14;11(11):
pubmed: 31739588
Chem Biol Interact. 2020 Feb 1;317:108963
pubmed: 31978391
Expert Rev Proteomics. 2005 Oct;2(5):719-29
pubmed: 16209651
Oncotarget. 2017 Feb 21;8(8):12855-12865
pubmed: 28030795
Sci Rep. 2020 Jan 16;10(1):424
pubmed: 31949209
Front Genet. 2019 Mar 01;10:133
pubmed: 30881380
J Clin Invest. 2020 Oct 1;130(10):5127-5141
pubmed: 32831296